A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 328
- Registration Number
- NCT00737048
A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic Pain
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2014-07-02
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 219
- Registration Number
- NCT00736957
A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-08-05
- Last Posted Date
- 2013-05-23
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 269
- Registration Number
- NCT00727987
An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 158
- Registration Number
- NCT00723528
A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients
Phase 1
Completed
- Conditions
- First Posted Date
- 2008-04-04
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 29
- Registration Number
- NCT00653406
A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain
- First Posted Date
- 2008-03-27
- Last Posted Date
- 2013-06-13
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 156
- Registration Number
- NCT00644787
An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2013-06-07
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 66
- Registration Number
- NCT00641667
An Exploratory Study of Nesiritide in Participants With Acute Heart Failure
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-06-25
- Last Posted Date
- 2014-02-03
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 67
- Registration Number
- NCT00490724
A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-11-07
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 394
- Registration Number
- NCT00396565
An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Target Recruit Count
- 398
- Registration Number
- NCT00301574
© Copyright 2024. All Rights Reserved by MedPath